The Children's Hospital of Philadelphia;The Childrens Hospital of Philadelphia
发明人:
Hakonarson, Hakon,Kao, Charlly
申请号:
AU2016318775
公开号:
AU2016318775A1
申请日:
2016.09.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
This application relates to methods of treating attention deficit hyperactivity disorder (ADHD), 22q deletion and/or duplication syndrome, and co-morbidities with a nonselective activator of metabotropic glutamate receptors, such as fasoracetam, for example, in subjects having a genetic alteration in at least one metabotropic glutamate receptor (mGluR) network gene.